Literature DB >> 7524602

Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation.

D C Jenkins1, I G Charles, S A Baylis, R Lelchuk, M W Radomski, S Moncada.   

Abstract

A panel of human colonic adenocarcinoma cell lines was examined both for expression of mRNAs of the nitric oxide synthase (NOS) gene family and for evidence of enzymic activity based on citrulline and nitrite (NO2-) formation. Reverse transcription-polymerase chain reaction (RT-PCR), revealed that all lines (SW480, SW620, DLD-1 and WiDr) expressed mRNA for the Ca(2+)-dependent endothelial (e)NOS, while SW480 cells also expressed the Ca(2+)-dependent neuronal (n)NOS. The mRNA for the Ca(2+)-independent inducible (i)NOS was expressed both by cytokine-stimulated and by unstimulated SW480, SW620 and DLD-1 cells, but none was seen at any time in the WiDr cells. There was, however, little correlation between mRNA expression and enzymic activity based on citrulline and NO2- formation. Thus none of the cell lines exhibited measurable Ca(2+)-dependent NOS activity, while Ca(2+)-independent NOS activity was seen in all but the WiDr cells. Furthermore, DLD-1 cells generated citrulline with resultant NO2- formation only after stimulation with lipopolysaccharide (LPS) and/or cytokines, while SW480 and SW620 did so constitutively. Thus RT-PCR studies indicate that tumour cells of similar epithelial origin display a diverse pattern of NOS gene family expression, and parallel biochemical studies clearly indicate that such expression does not always result in measurable enzymic activity leading to the generation of NO.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7524602      PMCID: PMC2033551          DOI: 10.1038/bjc.1994.409

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

Review 1.  The 1991 Ulf von Euler Lecture. The L-arginine: nitric oxide pathway.

Authors:  S Moncada
Journal:  Acta Physiol Scand       Date:  1992-07

2.  Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain.

Authors:  J Garthwaite; S L Charles; R Chess-Williams
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

4.  Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets.

Authors:  M W Radomski; D C Jenkins; L Holmes; S Moncada
Journal:  Cancer Res       Date:  1991-11-15       Impact factor: 12.701

5.  Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates.

Authors:  M Denis
Journal:  J Leukoc Biol       Date:  1991-04       Impact factor: 4.962

6.  Vascular endothelial cells synthesize nitric oxide from L-arginine.

Authors:  R M Palmer; D S Ashton; S Moncada
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

7.  Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase.

Authors:  S P Janssens; A Shimouchi; T Quertermous; D B Bloch; K D Bloch
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

8.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

9.  Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells.

Authors:  D J Stuehr; C F Nathan
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

10.  Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin.

Authors:  A K Nussler; M Di Silvio; T R Billiar; R A Hoffman; D A Geller; R Selby; J Madariaga; R L Simmons
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

View more
  28 in total

1.  Nitric oxide synthase immunoreactivity in human bladder carcinoma.

Authors:  M Shochina; Y Fellig; M Sughayer; G Pizov; K Vitner; D Podeh; A Hochberg; I Ariel
Journal:  Mol Pathol       Date:  2001-08

2.  Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy.

Authors:  Andrew G Sikora; Alexander Gelbard; Michael A Davies; Daisuke Sano; Suhendan Ekmekcioglu; John Kwon; Yared Hailemichael; Padmini Jayaraman; Jeffrey N Myers; Elizabeth A Grimm; Willem W Overwijk
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

3.  Acquired interferon gamma responsiveness during Caco-2 cell differentiation: effects on iNOS gene expression.

Authors:  A M Chavez; M J Morin; N Unno; M P Fink; R A Hodin
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

4.  Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter.

Authors:  M E de Vera; R A Shapiro; A K Nussler; J S Mudgett; R L Simmons; S M Morris; T R Billiar; D A Geller
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

5.  Effect of camptothecin on inducible nitric oxide synthase expression in the colon cancer SW480 cell line.

Authors:  Xiangdi Shen; Jian Chen; Rong Qiu; Xingli Fan; Ying Xin
Journal:  Oncol Lett       Date:  2015-09-02       Impact factor: 2.967

6.  Evidence for control of nitric oxide synthesis by intracellular transforming growth factor-beta1 in tumor cells. Implications for tumor development.

Authors:  P Lagadec; S Raynal; B Lieubeau; N Onier; L Arnould; V Saint-Giorgio; D A Lawrence; J F Jeannin
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

7.  Nitric oxide synthesis in patients with infective gastroenteritis.

Authors:  P Forte; R S Dykhuizen; E Milne; A McKenzie; C C Smith; N Benjamin
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 8.  NO to breast: when, why and why not?

Authors:  Shehla Pervin; Gautam Chaudhuri; Rajan Singh
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

Review 9.  Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers.

Authors:  Graciele Almeida de Oliveira; Robert Y S Cheng; Lisa A Ridnour; Debashree Basudhar; Veena Somasundaram; Daniel W McVicar; Hugo Pequeno Monteiro; David A Wink
Journal:  Antioxid Redox Signal       Date:  2016-10-31       Impact factor: 8.401

10.  Reductive heme-dependent activation of the n-oxide prodrug AQ4N by nitric oxide synthase.

Authors:  Clinton R Nishida; Paul R Ortiz de Montellano
Journal:  J Med Chem       Date:  2008-08-06       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.